Medical Marijuana (MJNA)

Website: www.MedicalMarijuanaInc.com

"In the First Quarter The Company Earned Net Income of Approximately $1.21 Million on Gross Revenues of $1.79 Million. That's an Increase of over 400% from Last Quarter and an Accumulative 12,000% plus Increase in Revenue since the same Quarter Last Year."

MJNA Investor Highlights

• Earnings Up 400% - In the first quarter the company earned net income of approximately $1.21 million on gross revenues of $1.79 million for the quarter ended March 31, 2012. That's an increase of over 400% from last quarter and an accumulative 12,000% plus increase in revenue since the same quarter last year. 
• Acquisitions - Acquired two additional Wellness Managed Services accounts which will generate estimated annual revenues of $1.7 million.
• Completed the acquisition of Dixie Elixirs & Edibles brand, intellectual property, proprietary formulas and extraction processes. In conjunction it formed Red Dice Holdings, as was announced in late April, to develop manufacturing and distribution partnerships for Dixie in every state and country that has legalized medical cannabis.
• Expansion - Begun hemp-based extraction product development beyond the medical marijuana industry, crossing into the nationally legal category of health and wellness with such products as sleep aids, topical and pain management. A market launch of the new products is expected by the end of the second quarter.
• Brought PhytoSPHERE systems on-line and will begin to market the benefits of its seed-to-sale product growth and cultivation technology in an attempt to secure licensing agreements worldwide.
• Growth - The Company has built additional raw ingredients supply sources on four continents in preparation for international expansion and it continues to develop international sales and distribution channels for its high-value extracts and compounds and related products produced by Dixie Elixirs and Edibles.
• Medical Marijuana, Inc.'s Wellness Managed Services (WMS) division plans to expand internationally to provide additional clinics, doctor's offices and wellness centers under the WMS umbrella.
• PhytoSPHERE plans to develop and launch a national/international marketing campaign in the third quarter to support sales of licensing agreements for its proprietary indoor planting, cultivation and extraction technology.
• Medical Marijuana, Inc. plans to establish a "Raw Ingredients Division" by the third quarter to provide raw ingredients and production services to other cannabis-based businesses.
• "With 16 states and Washington, D.C. allowing for legal use of medical marijuana and twelve more states with legalization initiatives on the ballot, MJNA is confident that the opportunity for continued growth in the US is exceptional. 
• Equally as important is the growing movement towards decriminalization outside the US and across Europe, which will allow MJNA to leverage what they have learned in mature legalized states like Colorado and California, and apply it to international markets. MJNA sees opportunity for significant national and international expansion by the end of 2012.
• Strong Backing - Cannabank, the private equity group that finances and incubates early stage acquisitions for MJNA, has agreed to finance several key transactions for the company including the European based pharmaceutical firm previously announced.
• Secured $4 million in non-dilution, non-recourse finance for the acquisition and development of strategic acquisitions. 
• Moving on Up - Commenced the first step in the process for its 15c2-11 filing status with BMA Securities. The filing is the company's securities to be quoted on the National Association of Securities Dealers' ("NASD") Over-the-Counter Bulletin Board ("OTCBB"). Once approved, this filing status causes another level of transparency which will be attractive to additional market makers and brokerage firms, thereby providing increased visibility to a broader set of investors.
• Shareholder Value - Retired 14,600,000 shares worth approximately $1.0 million dollars.
• Closed a $1.04 million upfront payment licensing transaction for high value hemp extracts.
• Intellectual Property - The Company is aggressively pursuing the acquisition and filing of additional product patents.
• Enormous Industry - Medical Marijuana and Industrial Hemp have over 55,000 known uses, all of which are under developed, undercapitalized and underutilized. It has been estimated that marijuana in the United States alone is a $110 billion market and the medical market makes up nearly $17 billion. Today the market is fractured in terms of international, state and local laws as well as with the business and people who participate in the industry. In our opinion, this is where MJNA, with its solid corporate structure, affords shareholders the biggest opportunity to profit.

Overview

Medical Marijuana Inc. (“MJNA”) is the first publicly held company vested in the medical marijuana and industrial hemp markets. The company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries.

These products range from patented and proprietary based cannabinoid products, to whole plant or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries.

The Company’s services are extensive and varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders. Services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA provides over 50 proprietary and patented cannabinoid “delivery methods” that are more “socially and medically acceptable” than smoking. Finally, MJNA services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal herb industry.

Medical Marijuana Inc.’s patented and proprietary technologies include the only pharmaceutical grade vertical Bio-Technology Company specializing in the standardization, production and extraction of medicinal cannabinoids. MJNA’s PhytoSPHERE Systems and their advanced plant growth technologies save significantly on resources necessary for production of medical grade cannabis. In addition to providing a medical grade end product, extracts and compounds, PhytoSPHERE Systems also includes pre-and-post production tracking, gemplasm references, packaging and processing to ensure consistency and genetic purity. 

Profile

Medical Marijuana's (MJNA) mission is to be the premier cannabis and hemp industry innovators, leveraging its team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. MJNA strives to create awareness within the industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

The company earned net income of approximately $1.21 million on gross revenues of $1.79 million for the quarter ended March 31, 2012. This represents a gross revenue increase of 400 plus percent quarter-over-quarter when compared to revenue of $430,000 for the quarter ended December 31, 2011 and an accumulative 12,000 plus percent increase in revenue since the same quarter last year. Operating expenses were approximately $580,000 for the quarter.

Recent News and Press Releases

Grassroots Research Publishes Research Report On Medical Marijuana Inc., With A Buy Rating and A Cohen Price Target

Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series

Medical Marijuana, Inc. Submits Updated 15c2-11 Filing

Medical Marijuana, Inc. Announces First Quarter 2012 Results

Dixie Elixirs & Edibles and PhytoSPHERE Systems, Portfolio Companies of Medical Marijuana, Inc, Grow Relationship with New Licensing Agreement

Medical Marijuana, Inc.’s Dixie Elixir and Edibles Brand to Launch First non-THC-Based Line of Health and Wellness Products

Medical Marijuana Inc (OTC: MJNA) Announces Its Wholly Owned Subsidiary Wellness Managed Services Signs An Additional Management Contract Increasing Annual Revenue By $1,700,000, Quarter Over Quarter Revenue Increase On Pace To Maintain 100% Compounded Quarterly

Medical Marijuana, Inc. and Dixie Elixirs Strike Innovative Agreement to Extend Dixie Elixirs Brand to Other MMJ Legal States

Medical Marijuana Inc. (OTC: MJNA) Acquires 80% of PhytoSPHERE Systems, LLC, A Leading Biotechnology Company Specializing in Pharmaceutical Grade Cannabis Compounds and Extracts

For the latest Quote and News on MJNA Click Here.

Outlook

Michael Llamas, President of Medical Marijuana comments on the Company's outlook.

"The first quarter of 2012 brought into clear focus all that we have been working towards since Cannabank's initial investment into Medical Marijuana, Inc. about a year ago," said Michael Llamas, President of Medical Marijuana, Inc. "We have spent this last year essentially getting our house in order by clarifying the growth strategy and systematically identifying, acquiring and growing early stage companies across the spectrum of the MMJ industry from product development to retail sales. As witnessed by our strong quarter-over-quarter and year-over-year growth, there is tremendous opportunity in this industry. We have the capital and the systems in place to buy, incubate and grow the best companies across multiple categories within the industry. At the same time, there is aggressive natural attrition of other companies and whole categories as the industry right sizes itself-which creates further opportunities and differentiation for Medical Marijuana, Inc. this truly is the perfect storm for acquiring income producing businesses.

"However, we also know that a 12,000 percent year-over-year growth is decidedly a factor of where we are in our growth cycle. We won't always have such favorable comparables moving forward past our second year. We do expect the comparable growth to normalize, but more importantly, we expect continued healthy growth in our core businesses as they begin to mature and the industry stabilizes. I'm equally proud that we have been able to maintain this rapid growth with a small core of dedicated and truly innovative employees and as a result, our operating costs have begun to stabilize since the close of the fourth quarter. We anticipate continued cost efficiency in line with future growth."

"With 16 states and Washington, D.C. allowing for legal use of medical marijuana and twelve more states with legalization initiatives on the ballot, we are confident that the opportunity for continued growth in the US, regardless of state boundaries, is exceptional," added Llamas. "Equally as important is the growing movement towards decriminalization outside the US and across Europe, which will allow us to leverage what we have learned in mature legalized states like Colorado and California, and apply it to international markets. We see opportunity for significant national and international expansion by the end of 2012 and we are currently putting in place the necessary supply chain and infrastructure elements to best position Medical Marijuana, Inc. and our shareholders to benefit from this growth."

Operations

PhytoSPHERE Systems LLC

PhytoSPHERE Systems, a subsidiary of MJNA, is a biotechnology company with an exclusive licensed, patented technology to build highly efficient vertical growth systems in compact, safe, pollutant free facilities throughout the US, while producing plant-based biocompounds in other countries that permit the cultivation and production of hemp and medical marijuana. This state of the art technology is fully contained, which means crops can be grown year round in any location using precise combinations of light, water, and nutrients to maximize production. 

Utilizing the TerraSphere System and its’ own state-of-the art proprietary extraction, purification, quality control and packaging processes, PhytoSPHERE Systems can assure its customers a reliable, consistent supply of high quality plant based compounds such as high value hemp oil, CBD,, plus numerous other cannabinoids. 

MJNA plans on building PhytoSPHERE facilities in countries that legally allow the cultivation of hemp for medical benefits. A major concern for sellers of natural product drugs, medical herbs, nutraceuticals, and cosmeceuticals is the unreliable supply of top quality active ingredients. Cultivation of source plants is erratic and the quality of extracts is highly uneven. With PhytoSPHERE MJNA can establish itself as the leading company serving this exploding market.

Dixie Elixir & Edibles

MJNA's, portfolio company, Red Dice Holdings, LLC, owns the exclusive rights to license the Dixie Elixirs & Edibles brand, consisting of more than forty medicinal hemp-based infused products including medicated beverages and tonics, pharmaceutical grade hemp capsules, medicated lozenges and edibles, as well as a full line of topicals and salves as part of the Dixie Botanicals line of products which was recently featured on National Geographic's series American Weed. As one of the world's most recognized medicinal hemp infused brands, Dixie products are distributed currently in over 400 retail locations in Colorado alone and will be expanding rapidly to other states that allow for medical cannabis. Red Dice Holdings, LLC through its Dixie brand focuses on the development of innovative medically and socially acceptable delivery systems.

Red Dice Holdings, LLC is licensing its proprietary formulas, manufacturing and extraction technology and delivery systems to other socially conscious companies in an effort to rapidly expand its distribution base. Currently, 16 states plus Washington DC have legalized the use of medical cannabis products. 

HempMeds RX 

MJNA's Hemp Med Rx division is the world’s premier developer of specialty health and wellness products derived from Hemp extracts and compounds. In a recent press release, MJNA announced HepMeds RX would begin selling three new Cannabidiol (CBD) products in association with Dixie Elixirs. These products will contain significant quantities of high concentration CBD hemp oil while containing zero THC. 

By August 2012, MJNA intends to launch a mail order campaign and online e-commerce platform that will allow individuals throughout the U. S. to purchase these products since they contain no THC. The U. S. availability will be followed closely by distribution in international markets including Europe via several key product distribution relationships that are currently under negotiation.

This is a huge opportunity for MJNA to generate substantial revenue, and for investors to make big profits from the stock. 

Wellness Managed Services 

MJNA’s Wellness Managed Services manages and develops Health and Wellness facilities throughout North America. Wellness Managed Services will provide patients with the finest Cannabidiol (CBD) products for health and wellness, as well as providing ancillary services for the facility in terms of tracking, accounting, patient management, insurance reimbursement (where applicable), merchant processing and other services. 

Since the end of the 4th quarter 2011, Wellness Managed Services has actively been acquiring and developing its services. This subsidiary is in negotiations for several additional facilities in Canada, California, Colorado and Arizona at present and is looking to further expand throughout the US as well as develop an International Division. With the execution of the large contract announced on April 24th, Wellness Managed Services will begin to integrate the MJNA Portfolio of products and services toward the various facilities in our system.

Ace Hydro, a division of MJNA, is a start-up business that will acquire existing hydroponic businesses nationwide. MJNA will integrate these businesses into the Ace Hydro brand, thereby lowering operating costs and providing these retailers with unmatched support and competitive advantages. Under the Ace Hydro umbrella, retailers can expect lower overhead, greater economic security, future financing, and expansion opportunities, all while retaining the ability to manage the store’s daily operations.

MMI Nutraceuticals is a subsidiary of Medical Marijuana Inc. that deals in many different types of products that include CBD (Cannabidiol) and THC Free brands. Nutraceutical is defined as a dietary supplement providing health benefits along with basic nutritional value. MMI Nutraceuticals has 50 patented, proprietary technologies and socially acceptable delivery methods.

MMI Biotechnology 

MMI Biotechnology manufactures and builds specialty equipment and technology for the pharmaceutical, medical herbal and the nutraceutical industry. It does so by engaging in the acquisition of companies and business units, which manufacture or build biotechnology and equipment, serving the need for hemp agricultural and medicinal technology market. MMI Biotechnology has been licensed by the Hemp Deposit and Distribution Corporation for the whole of the western hemisphere.